• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Devin Incerti on the Need for Global Value Assessment to Be Adaptable

Video

Devin Incerti, PhD, lead economist, Innovation and Value Initiative, discusses the need for global value assessments to be adaptable for countries that place emphasis on certain values.

Devin Incerti, PhD, lead economist, Innovation and Value Initiative, discusses the need for global value assessments to be adaptable for countries that place emphasis on certain values.

Transcript

Is there a need for a global value assessment to be adaptable to different countries who might place emphasis on certain values?

I think that’s going to be very important. So, while we do have conventional cost-effectiveness and it works quite well, it’s also very context specific. So, take one example: people have come up with this concept called the fair innings argument. It basically says that there may be some cases where individuals live a shorter amount of time. So, if you’re a really sick young infant, if you’re a really sick young kid, your life expectancy might be much shorter than someone who lives a full lifespan. And because of that, we might want some concept of equity where we think about, maybe we want to value the treatments that are going to treat patients that are very sick, very young, maybe those with rare diseases more than we value a treatment that affects the entire population. So, these are all equity considerations that are really, they’re not mathematical. They reflect the value of a particular society.

Related Videos
Mei Wei, MD.
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Sandra Cueller, PharmD
Ticiana Leal, MD
James Chambers, PhD
Mabel Mardones, MD.
Dr Bonnie Qin
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.